Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract

NCT06430372 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Carcinoma
Dysplasia
Gastrointestinal Polyp

Interventions

DRUG: Bev-ICG
DEVICE: NIR-II fluorescence endoscopy platform

Sponsor

Institute of Automation, Chinese Academy of Sciences